Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis.
Saved in:
| Title: | Albumin-EDTA-Vanadium Is a Powerful Anti-Proliferative Agent, Following Entrance into Glioma Cells via Caveolae-Mediated Endocytosis. |
|---|---|
| Authors: | Cooper I; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat-Gan 52620, Israel.; School of Psychology, The Reichman University, Herzliya 4610101, Israel.; The Nehemia Rubin Excellence in Biomedical Research, The TELEM Program, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52620, Israel., Ravid O; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat-Gan 52620, Israel., Rand D; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat-Gan 52620, Israel., Atrakchi D; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat-Gan 52620, Israel., Shemesh C; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat-Gan 52620, Israel., Bresler Y; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat-Gan 52620, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel., Ben-Nissan G; Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel., Sharon M; Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel., Fridkin M; Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel., Shechter Y; Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot 76100, Israel. |
| Source: | Pharmaceutics [Pharmaceutics] 2021 Sep 25; Vol. 13 (10). Date of Electronic Publication: 2021 Sep 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
